Recent SEC Filings
| Entity | Filing | Filed On |
|---|---|---|
| GRAIL, Inc. | 10-Q | 13 Nov 2024 |
| Elicio Therapeutics, Inc. | 10-Q | 13 Nov 2024 |
| Roadzen Inc | 10-Q | 13 Nov 2024 |
| Maplebear Inc. | 10-Q | 13 Nov 2024 |
| Tarsus Pharmaceuticals, Inc. | 10-Q | 13 Nov 2024 |
| MEDICINOVA INC | 10-Q | 13 Nov 2024 |
| Palladyne AI Corp. | 10-Q | 13 Nov 2024 |
| KULR Technology Group, Inc. | 10-Q | 13 Nov 2024 |
| Vireo Growth Inc. | 10-Q | 13 Nov 2024 |
| Adaptimmune Therapeutics PLC | 10-Q | 13 Nov 2024 |
| American Oncology Network, Inc. | 10-Q | 13 Nov 2024 |
| Microbot Medical Inc. | 10-Q | 13 Nov 2024 |
| CF Acquisition Corp. VII | QUARTERLY REPORT | 13 Nov 2024 |
| BrightView Holdings, Inc. | 10-K | 13 Nov 2024 |
| BrightView Holdings, Inc. | 10-K | 13 Nov 2024 |
| 4D Molecular Therapeutics Inc | 10-Q | 13 Nov 2024 |
| Natural Alternatives International Inc | FORM 10-Q | 13 Nov 2024 |
| RenovoRx, Inc. | 10-Q | 13 Nov 2024 |
| Cantor Equity Partners, Inc. | QUARTERLY REPORT | 13 Nov 2024 |
| Dermata Therapeutics, Inc. | FORM 10-Q | 13 Nov 2024 |
